doi:10.1007/s12250-010-3096-2

[1]
Wei-wei Gai, Yan Zhang, Di-han Zhou, Yao-qing Chen, Jing-yi Yang, Hui-min Yan, 2011: PIKA Provides an Adjuvant Effect to Induce Strong Mucosal and Systemic Humoral Immunity Against SARS-CoV^*, Virologica Sinica, 26, 81-94. doi: 10.1007/s12250-011-3183-z
[2]
Chuan-hai ZHANG, Xin-jian LIU, Yi-fei WANG, Jia-hai LU, Huan-ying ZHENG, Sheng XIONG, Mei-ying ZHANG, Qiu-ying LIU, 2007: Immune Responses and Histopathological Changes in Rabbits Immunized with Inactivated SARS Coronavirus*, Virologica Sinica, 22, 360-365.
[3]
刘昕, 刘胜旺, 孔宪刚, 张庆霞, 荣骏弓, 韩宗玺, 邵昱昊, 2006: Characterization of Spike Gene of Infectious Bronchitis Coronavirus CK/CH/ LDL97Ⅰ/97 Isolated in China, Virologica Sinica, 21, 68-70.
[4]
Tiandan Xiang, Junzhong Wang, Xin Zheng, 2022: The humoral and cellular immune evasion of SARS-CoV-2 Omicron and sub-lineages, Virologica Sinica, 37, 786-795. doi: 10.1016/j.virs.2022.11.007
[5]
Peng Zhou, Zhenggang Han, Lin-Fa Wang, Zhengli Shi, 2013: Identification of Immunogenic Determinants of the Spike Protein of SARS-like Coronavirus, Virologica Sinica, 28, 92-96. doi: 10.1007/s12250-013-3292-y
[6]
Yuming Li, Yanhong Tang, Xiaoqian Wang, Airu Zhu, Dongdong Liu, Yiyun He, Hu Guo, Jie Zheng, Xinzhuo Liu, Fengyu Chi, Yanqun Wang, Zhen Zhuang, Zhaoyong Zhang, Donglan Liu, Zhao Chen, Fang Li, Wei Ran, Kuai Yu, Dong Wang, Liyan Wen, Jianfen Zhuo, Yanjun Zhang, Yin Xi, Jingxian Zhao, Jincun Zhao, Jing Sun, 2024: Characterization of humoral immune responses against SARS-CoV-2 accessory proteins in infected patients and mouse model, Virologica Sinica, 39, 414-421. doi: 10.1016/j.virs.2024.04.005
[7]
Yang Zheng, Qing Zhang, Ashaq Ali, Ke Li, Nan Shao, Xiaoli Zhou, Zhiqin Ye, Xiaomin Chen, Shanshan Cao, Jing Cui, Juan Zhou, Dianbing Wang, Baidong Hou, Min Li, Mengmeng Cui, Lihua Deng, Xinyi Sun, Qian Zhang, Qinfang Yang, Yong li, Hui Wang, Yake Lei, Bo Yu, Yegang Cheng, Xiaolin Tong, Dong Men, Xian-En Zhang, 2021: Sustainability of SARS-CoV-2 Induced Humoral Immune Responses in COVID-19 Patients from Hospitalization to Convalescence Over Six Months, Virologica Sinica, 36, 869-878. doi: 10.1007/s12250-021-00360-4
[8]
Xiuli Shen, Shuhui Wang, Yanling Hao, Yuyu Fu, Li Ren, Dan Li, Wenqi Tang, Jing Li, Ran Chen, Meiling Zhu, Shuo Wang, Ying Liu, Yiming Shao, 2024: DNA vaccine prime and replicating vaccinia vaccine boost induce robust humoral and cellular immune responses against MERS-CoV in mice, Virologica Sinica, 39, 490-500. doi: 10.1016/j.virs.2024.05.005
[9]
马翠卿, 周育森, 王弋嘉, 郭彦, 管洁, 魏林, 何玉先, 2005: Expression and Immunogenicity Analysis of the Receptor-binding Region of SARS-CoV Spike Protein, Virologica Sinica, 20, 472-475.
[10]
Yanxing Cai, Wei Xu, Chenjian Gu, Xia Cai, Di Qu, Lu Lu, Youhua Xie, Shibo Jiang, 2020: Griffithsin with A Broad-Spectrum Antiviral Activity by Binding Glycans in Viral Glycoprotein Exhibits Strong Synergistic Effect in Combination with A Pan-Coronavirus Fusion Inhibitor Targeting SARS-CoV-2 Spike S2 Subunit, Virologica Sinica, 35, 857-860. doi: 10.1007/s12250-020-00305-3
[11]
Xueqin Zhu, Yang Liu, Jiao Guo, Junyuan Cao, Zonglin Wang, Gengfu Xiao, Wei Wang, 2021: Effects of N-Linked Glycan on Lassa Virus Envelope Glycoprotein Cleavage, Infectivity, and Immune Response, Virologica Sinica, 36, 774-783. doi: 10.1007/s12250-021-00358-y
[12]
李静, 叶正旭, 杨守京, 李铠男, 高娟, 刘彦仿, 2006: Hsp70-NP Recombinant Protein Enhances HTNV NP Specific Cellular Immune Response in vivo, Virologica Sinica, 21, 339-342.
[13]
Wen-Hua Kong, Rong Zhao, Jun-Bo Zhou, Fang Wang, De-Guang Kong, Jian-Bin Sun, Qiong-Fang Ruan, Man-Qing Liu, 2020: Serologic Response to SARS-CoV-2 in COVID-19 Patients with Different Severity, Virologica Sinica, 35, 752-757. doi: 10.1007/s12250-020-00270-x
[14]
Wen-Jun Tian, Xiu-Zhong Zhang, Jing Wang, Jian-Feng Liu, Fu-Huang Li, Xiao-Jia Wang, 2024: Calmodulin-like 5 promotes PEDV replication by regulating late-endosome synthesis and innate immune response, Virologica Sinica, 39, 501-512. doi: 10.1016/j.virs.2024.05.006
[15]
Jiang-Fan Li, Lei He, Yong-Qiang Deng, Shu-Hui Qi, Yue-Hong Chen, Xiao-Lu Zhang, Shi-Xiong Hu, Rui-Wen Fan, Guang-Yu Zhao, Cheng-Feng Qin, 2021: Generation and Characterization of a Nanobody Against SARS-CoV, Virologica Sinica, 36, 1484-1491. doi: 10.1007/s12250-021-00436-1
[16]
Haili Zhang, Hongli Jin, Feihu Yan, Yumeng Song, Jiaxin Dai, Cuicui Jiao, Yujie Bai, Jingxuan Sun, Di Liu, Shen Wang, Mengyao Zhang, Jilong Lu, Jingbo Huang, Pei Huang, Yuanyuan Li, Xianzhu Xia, Hualei Wang, 2023: An inactivated recombinant rabies virus chimerically expressed RBD induces humoral and cellular immunity against SARS-CoV-2 and RABV, Virologica Sinica, 38, 244-256. doi: 10.1016/j.virs.2022.12.006
[17]
Yongmei Liu, Jianhua Lu, Haoting Zhan, Wenfang Yuan, Xiaomeng Li, Haiyan Kang, Haolong Li, Yongliang Chen, Linlin Cheng, Xingli Sun, Haojie Zheng, Wei Wang, Erhei Dai, Yongzhe Li, 2023: Inactivated SARS-CoV-2 booster vaccine enhanced immune responses in patients with chronic liver diseases, Virologica Sinica, 38, 723-734. doi: 10.1016/j.virs.2023.07.005
[18]
Lingqian Tian, Qiuhong Liu, Rongjuan Pei, Yingshan Chen, Chonghui Xu, Jielin Tang, Hao Sun, Kunpeng Liu, Qi Yang, Lei Yang, Leshan Li, Yongli Zhang, Yuan Zhou, Chao Shan, Xue Hu, Xinwen Chen, Yun Wang, 2022: Comparison of viral propagation and drug response among SARS-CoV-2 VOCs using replicons capable of recapitulating virion assembly and release, Virologica Sinica, 37, 695-703. doi: 10.1016/j.virs.2022.06.008
[19]
Ashutosh Singh, Rahul Soloman Singh, Phulen Sarma, Gitika Batra, Rupa Joshi, Hardeep Kaur, Amit Raj Sharma, Ajay Prakash, Bikash Medhi, 2020: A Comprehensive Review of Animal Models for Coronaviruses: SARS-CoV-2, SARS-CoV, and MERS-CoV, Virologica Sinica, 35, 290-304. doi: 10.1007/s12250-020-00252-z
[20]
张珈敏, 郑从义, 胡远扬*, 2003: Morphology and Its M orphogenesis of the SARS-CoV Hb Strain in vitro, Virologica Sinica, 18, 404-406.